Sartorius Stedim Biotech S.A. SDMHF
249.50 USD -5.06 (-1.99%)
At close·Oct 30, 2026, 4:00 PM EDT
178.30 52-week range 264.30
- YTD
- +1.42%
- 1 year
- +3.10%
Altman Z-Score
4.90 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
P/E 76.7×
P/S 6.9×
P/B 5.0×
P/FCF 140×
EV/EBITDA 26.0×
EV/Sales 7.6×
FCF Yield 0.7%
Gross Margin 45.3%
Operating Margin 18.5%
Net Margin 9.0%
ROE 6.5%
ROIC 5.4%
ROA 3.3%
Revenue 6.7%
Operating Income 48.1%
EPS (diluted) 50.8%
Free Cash Flow -69.4%
Current Ratio 1.0×
Quick Ratio 0.5×
Debt / Equity 0.6×
Net Debt / EBITDA 2.5×
Interest Coverage 3.6×
Dividend Yield 0.3%
Payout Ratio 25.3%
Annual · latest fiscal year ends 2025-12-31